CClinicalTrials.gg
CompletedNCT03513120Updated Dec 19, 2020

Return to Sport After Posterior Spinal Fusion

An observational study in Adolescent Idiopathic Scoliosis and Posterior Spinal Fusion, sponsored by University of Colorado, Denver. Completed at 1 site in United States. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2020-12-19.

Sponsored by University of Colorado, Denver · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
10 Years to 18 Years
Sex
All
01

Study summary

The primary purpose of this prospective study is to determine when adolescent athletes with idiopathic scoliosis are able to return to sports participation after posterior spinal fusion surgery.

Read the detailed description

The investigators aim to determine at what time subjects return to athletic activity, and how long after surgery they are performing at pre-surgical levels. The investigators will enroll adolescent athletes that meet the inclusion criteria below, and follow their postoperative activity level with standardized activity questionnaires on a monthly basis until the subject reaches their baseline pre-surgical performance level. The investigators primary aim is to determine at what time patients return to sports without any restrictions to contact level or type of play. The investigators secondary aim is to quantitatively assess when patients are able to compete at their prior level of play as determined by self-assessment surveys, as well as identify any post-operative complications in these patients after return to sports.

02

Conditions studied

  • Adolescent Idiopathic Scoliosis
  • Posterior Spinal Fusion

Browse trials for

Keywords

  • Adolescent Idiopathic Scoliosis
  • Posterior Spinal Fusion
  • Return to Sport
03

In context

Scoliosis

594 studies on the registry are indexed under Scoliosis; 139 are open to participants now.

This study's enrollment of 30 is below the median of 89 across 233 observational studies indexed under Scoliosis.

Browse Scoliosis studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All enrolled subjects will be competitive athletes with a diagnosis of adolescent idiopathic scoliosis and plans to undergo posterior spinal fusion.

Inclusion criteria

  • Level of play: high school or club level
  • Frequency of play at above level: >3mos/year
  • Age: 10-18 years of age (inclusive)
  • Sports: at least one sport, contact, non-contact, or collision. No sports exclusion criteria
  • Spinal deformity criteria: Adolescent idiopathic scoliosis, curve size 40-75 degrees

Exclusion criteria

Exclusion Criteria:

  • Play at recreational/intramural level
  • Non-English Speaking Patient
  • Sports participation \<3 mos/year
  • Non idiopathic etiology or curves >75 degrees
  • Treatment outside of Children's Hospital Colorado provider care network
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Return to Sport

    Identify at what time patients return to sports without any restrictions.

    Time frame: Less than 1 year following surgery

Secondary outcomes

  1. Physical Function Levels

    Identify at what time patients report physical function returns to their pre-surgical levels.

    Time frame: Less than 1 year following surgery

  2. Postoperative Complications

    Identify any postoperative complications related to release to full activity one month after surgery.

    Time frame: Up to 1 year follow up

07

Study locations

1 site
  • Children's Hospital Colorado
    Aurora, Colorado 80045, United States
08

References and documents

Individual participant data

Plan to share: No — No IPD will be shared with other researchers

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03513120
Lead sponsor
University of Colorado, Denver
Responsible party
Sponsor
First posted
May 1, 2018
Start date
Mar 8, 2018
Primary completion
Aug 31, 2020
Completion
Aug 31, 2020
Last update
Dec 19, 2020

Study contacts

Sumeet Garg, MD
study director · Children's Hospital Colorado
Allison Tetreault, MD
principal investigator · University of Colorado School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion